Board Advisory Committees

The following standing advisory committees of the Board report to the BoD:

In addition, the Research Management Committee (RMC) and the International Scientific Excellence Committee (ISEAC) also report to the Board.


.

BUDGET AND AUDIT COMMITTEE

This standing advisory committee undertakes quarterly reviews of AllerGen Network finances, oversees the development of budgets and financial reports, recommends on financial and investment policies, oversees annual financial audits, and reviews and recommends auditors for BoD approval. This Committee meets annually with the Network auditors to review financial audit results.

Committee Members

Donald Green (Chair)


Don-GreenDonald Green (interim Chair)


Chair and CEO, Greenfleet Ltd.

For 35 years, Donald Green was Chair and CEO of the international auto parts manufacturer Tridon Ltd., and is now Chair and CEO of Greenfleet Ltd., a private investment company.

Pieter Cullis


CullisPieter Cullis, BSc, PhD


Professor, Department of Biochemistry and Molecular Biology; Director, Life Sciences Institute, University of British Columbia

Dr. Cullis is an internationally recognized pioneer and leader in the physical properties and functional roles of lipids in biological membranes and liposomal drug delivery systems.

Christine Hampson


hampsonChristine Hampson, PhD


President and CEO, The Sandbox Project

Dr. Hampson is President & CEO of The Sandbox Project Charity, which aims to make measurable progress against international health indicators within the next five years, improving health outcomes with respect to injury prevention, obesity, mental health, and the environment in particular.

Diana Royce


dianaroyceDiana Royce, EdD


Managing Director and COO, AllerGen NCE Inc.

Dr. Royce has over 30 years of experience in the post-secondary and health sectors related to public consultation and research, program implementation, strategic and operational planning, network administration, partnership and public policy development, advocacy, fundraising, knowledge mobilization, conference planning and meeting facilitation.

Lorne Tyrrell


TyrrellLorne Tyrrell, OC, AOE, MD, PhD, FRCP(C), FRSC, FCAHS


Distinguished University Professor and Director, LiKaShing Institute of Virology, University of Alberta

Dr. Tyrrell, an exceptional teacher, compassionate physician and accomplished researcher, has positioned the University of Alberta and Canada as a world leader in hepatitis research and treatment. He was awarded a Killam Prize in 2015.

Sector: Clinical/Academic


.

EXECUTIVE AND NOMINATING COMMITTEE

This advisory standing committee advises on good governance practices, including policies and procedures consistent with the Network’s objectives, for Board review and approval, proposes Board meeting agenda items in advance of Board meetings, and takes action on behalf of the Board in situations where a full Board meeting is not possible and exigent circumstances warrant a special meeting.

Committee Members

Pieter Cullis (Chair)


CullisPieter Cullis, BSc, PhD


Professor, Department of Biochemistry and Molecular Biology; Director, Life Sciences Institute, University of British Columbia

Dr. Cullis is an internationally recognized pioneer and leader in the physical properties and functional roles of lipids in biological membranes and liposomal drug delivery systems.

Judah Denburg


jdsmallJudah Denburg, MD, FRCPC


Scientific Director and CEO, AllerGen NCE Inc.

As Scientific Director of AllerGen, Dr. Denburg helps steer an innovative and inter-disciplinary research program. Dr. Denburg’s main research thrusts include examination of the mechanisms of allergic inflammation, with particular emphasis on hemopoietic cytokines and their role in activating the differentiation and recruitment of inflammatory cells such as eosinophils, basophils and mast cells.

Donald Green


Don-GreenDonald Green (interim Chair)


Chair and CEO, Greenfleet Ltd.

For 35 years, Donald Green was Chair and CEO of the international auto parts manufacturer Tridon Ltd., and is now Chair and CEO of Greenfleet Ltd., a private investment company.

Jean-François LePrince


LeprinceJean-François LePrince


Managing Partner, CTI Life Sciences Fund

Mr. Leprince has over 30 years of experience with large pharmaceutical companies; he has overseen the largest R&D spending of any of the multinational pharmaceutical companies operating in Canada.

Diana Royce


dianaroyceDiana Royce, EdD


Managing Director and COO, AllerGen NCE Inc.

Dr. Royce has over 30 years of experience in the post-secondary and health sectors related to public consultation and research, program implementation, strategic and operational planning, network administration, partnership and public policy development, advocacy, fundraising, knowledge mobilization, conference planning and meeting facilitation.

Lorne Tyrrell


TyrrellLorne Tyrrell, OC, AOE, MD, PhD


Professor and CIHR/GSK Chair in Virology, University of Alberta

Dr. Tyrrell, an exceptional teacher, compassionate physician and accomplished researcher, has positioned the University of Alberta and Canada as a world leader in hepatitis research and treatment.